![Deborah Autor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deborah Autor
Direktor/Vorstandsmitglied bei
AMNEAL PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 31.05.2026
Profil
Deborah M.
Autor is currently Chief Executive Officer at Autor Strategies LLC since 2022.
Ms. Autor serves as Independent Director at Amneal Intermediate, Inc. since 2022 and at Amneal Pharmaceuticals, Inc. since 2023.
Ms. Autor holds the position of Director at Parenteral Drug Association.
Ms. Autor is Director & Chief Policy Officer at Hims & Hers Health, Inc. starting in 2025.
Former roles include Chairman at FDA Alumni Association in 2013, Compliance Director at Center for Drug Evaluation & Research, Independent Director at Pardes Biosciences, Inc. from 2021 to 2023, Director at Antimicrobial Resistance Industry Alliance, SVP-Strategic Global Quality & Regulatory Policy at Mylan, Inc., Head-Strategic Global Quality & Regulatory Policy at Mylan NV from 2013 to 2019, Vice President & Global Head-Regulatory Excellence at AstraZeneca Pharmaceuticals LP from 2019 to 2021, Deputy Commissioner-Global Regulatory Operations at US Food & Drug Administration, and Trial Attorney-Consumer Litigation at US Department of Justice.
Education includes undergraduate studies at Barnard College and graduate studies at Boston University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 48.961 ( 0,02 % ) | 1 Mio $ | 31.05.2026 | |
| 11.05.2026 | 93.660 ( 0,03 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Deborah Autor
| Unternehmen | Position | Beginn |
|---|---|---|
| AMNEAL PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 07.11.2023 |
| HIMS & HERS HEALTH, INC. | Direktor/Vorstandsmitglied | 15.11.2024 |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 29.07.2022 |
Autor Strategies LLC | Vorstandsvorsitzender | 01.01.2022 |
Parenteral Drug Association
 Parenteral Drug Association Miscellaneous Commercial ServicesCommercial Services Operates as a scientific membership association that connects professionals in pharmaceutical science and regulation by offering global conferences, training courses, technical publications | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Deborah Autor
| Unternehmen | Position | Ende |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 30.08.2023 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Corporate Officer/Principal | 01.12.2021 |
Mylan NV
 Mylan NV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01.08.2019 |
FDA Alumni Association | Vorsitzender | 01.01.2013 |
| ░░░░░░ ░░░ ░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░░ | ░░░░░░░░░░ ░░░░░░░ | - |
Ausbildung von Deborah Autor
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Barnard College
 Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
US Department of Justice
 US Department of Justice General GovernmentGovernment Department of the United States government | Government |
Parenteral Drug Association
Parenteral Drug Association Miscellaneous Commercial ServicesCommercial Services Operates as a scientific membership association that connects professionals in pharmaceutical science and regulation by offering global conferences, training courses, technical publications | Commercial Services |
FDA Alumni Association | |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Hims & Hers Health, Inc.
 Hims & Hers Health, Inc. Medical/Nursing ServicesHealth Services Operates as a telehealth consultation platform and wholesales medicines | Health Services |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Autor Strategies LLC | |
Amneal Pharmaceuticals, Inc.
 Amneal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes essential medicines | Health Technology |
